MeiraGTx Holdings plc

Publicly traded New York company in biological products, (no diagnostic substances) (Nasdaq: MGTX).[5]

Overview

MeiraGTx Holdings plc is a publicly traded company listed on Nasdaq under the ticker MGTX [2]. The company maintains its headquarters at 655 Third Avenue, Suite 1115, New York, NY, 10017 [1]. According to Securities and Exchange Commission filings, MeiraGTx operates in the biological products industry, specifically in the manufacture of biological products excluding diagnostic substances [3]. In its most recent annual report, the company reported revenue of $15.9 million for the year ending December 31, 2022, and held total assets of $244.4 million [4].

Business address: 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017. [1]

MeiraGTx lists its address as 92 York Street, London, England, W1H 1. [6]

Financials

Reported revenue of $15.9 million for the year ending 2022-12-31 and total assets of $244.4 million in its most recent annual report to the SEC. [4]

Financials

TickerNASDAQ: MGTXMarket value$1.1BShare price10.79 USD
2026-1010.79 USD-39% since 2021
2021-11low 4 · high 242026-10

Market data, not a filing. Read 2026-10-02.

Revenue as reported

Something wrong or missing? Send an update. Fixed within 24 hours.